Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
May act as a specification marker at earliest stage specification of lymphocytes between B- and T-cell development. Additionally we are shipping LY6D Proteins (7) and LY6D Kits (1) and many more products for this protein.
Showing 9 out of 13 products:
Mouse (Murine) Monoclonal LY6D Primary Antibody for CyTox, IHC (fro) - ABIN2689823
Boyd, Tucek, Godfrey, Izon, Wilson, Davidson, Bean, Ladyman, Ritter, Hugo: The thymic microenvironment. in Immunology today 1993
Show all 6 references for ABIN2689823
Mouse (Murine) Monoclonal LY6D Primary Antibody for Act, FACS - ABIN2661969
Mansson, Zandi, Welinder, Tsapogas, Sakaguchi, Bryder, Sigvardsson: Single-cell analysis of the common lymphoid progenitor compartment reveals functional and molecular heterogeneity. in Blood 2010
Show all 5 references for ABIN2661969
Mouse (Murine) Monoclonal LY6D Primary Antibody for FACS - ABIN2662798
Inlay, Bhattacharya, Sahoo, Serwold, Seita, Karsunky, Plevritis, Dill, Weissman: Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. in Genes & development 2009
Show all 5 references for ABIN2662798
Expression of RAG-1 (show RAG1 Antibodies) and display of Ly6D are both milestone events, but they are neither synchronized nor dependent on each other.
Data show that ten genes (Fsp27 (show CIDEC Antibodies), Aqp4 (show AQP4 Antibodies), Cd36 (show CD36 Antibodies), Ly6d, Scd1 (show SCD Antibodies), Hsd3b5, Syt1 (show SYT1 Antibodies), Cyp7b1 (show CYP7B1 Antibodies), and Tff3 (show TFF3 Antibodies)) showed significant associations among their expressions and the degree of hepatic steatosis.
identified Ly6d, which divides CLPs (show CLPS Antibodies) into two distinct populations: one that retains full in vivo lymphoid potential and produces more thymocytes at early timepoints than LMPP, and another that behaves essentially as a B-cell progenitor
LY6D is the most highly up-regulated in HTR (show F2R Antibodies)-8/SVneo-SP cells and it has potential to maintain cell proliferation of the cells. it is important for the maintenance of the cells.
E48 expression was strong and diffuse in non-neoplastic squamous epithelium, and decreased with progression to laryngeal squamous cell carcinoma. Poorly differentiated tumors had fewer E48-positive cells than well- to moderately- differentiated cases.
induction of LY6D expression is triggered through a pathway regulated by ATM (show ATM Antibodies), CHK2 (show CHEK2 Antibodies) and p53 (show TP53 Antibodies)
May act as a specification marker at earliest stage specification of lymphocytes between B- and T-cell development. Marks the earliest stage of B-cell specification.
, lymphocyte antigen 6D
, thymocyte B-cell antigen
, e48 antigen